RIFAXIMIN IMPROVES BOTH ABDOMINAL PAIN AND BLOATING IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA: A COMPOSITE ENDPOINT ANALYSIS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS

被引：0
|
作者：
Lacy, Brian E.
Chang, Lin
Rao, Satish S.
Heimanson, Zeev
Sayuk, Gregory S.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Fr255
引用
收藏
页码：S281 / S281
页数：1
相关论文
共 50 条
  • [31] A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating
    Kim, HJ
    Roque, MIV
    Camilleri, M
    Stephens, D
    Burton, DD
    Baxter, K
    Thomforde, G
    Zinsmeister, AR
    NEUROGASTROENTEROLOGY AND MOTILITY, 2005, 17 (05): : 687 - 696
  • [32] Plecanatide for Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome-Constipation: Analysis of Abdominal Bloating From Four Randomized Phase 3 Clinical Trials
    Franklin, Howard
    Sayuk, Gregory S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S291 - S291
  • [33] Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial
    Hamide Khorram Pazhouh
    Seyyd Musa al-Reza Hosseini
    Ali Taghipour
    Shokouhsadat Hamedi
    Mohammadreza Noras
    Chinese Journal of Integrative Medicine, 2020, 26 (10) : 729 - 735
  • [34] Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial
    Pazhouh, Hamide Khorram
    Hosseini, Seyyd Musa al-Reza
    Taghipour, Ali
    Hamedi, Shokouhsadat
    Noras, Mohammadreza
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2020, 26 (10) : 729 - 735
  • [35] Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial
    Hamide Khorram Pazhouh
    Seyyd Musa alReza Hosseini
    Ali Taghipour
    Shokouhsadat Hamedi
    Mohammadreza Noras
    Chinese Journal of Integrative Medicine , 2020, (10) : 729 - 735
  • [36] Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial
    Hamide Khorram Pazhouh
    Seyyd Musa al-Reza Hosseini
    Ali Taghipour
    Shokouhsadat Hamedi
    Mohammadreza Noras
    Chinese Journal of Integrative Medicine, 2020, 26 : 729 - 735
  • [37] Plecanatide simultaneously improves multiple symptoms of irritable bowel syndrome with constipation (IBS-C): A unique composite endpoint analysis of randomized, phase 3 trials
    Sayuk, G. S.
    Laitman, A. P.
    Allen, C.
    Schoenfeld, P. S.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35
  • [38] Characterization of Abdominal Pain Response to Rifaximin in Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D), by Baseline Pain Severity
    Lembo, Anthony
    Heimanson, Zeev
    Cash, Brooks D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S251 - S251
  • [39] CHARACTERIZATION OF ABDOMINAL PAIN RESPONSE TO RIFAXIMIN IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D), BY BASELINE PAIN SEVERITY
    Lembo, Anthony
    Heimanson, Zeev
    Cash, Brooks D.
    GASTROENTEROLOGY, 2019, 156 (06) : S775 - S775
  • [40] Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial
    Cash, Brooks D.
    Pimentel, Mark
    Rao, Satish S. C.
    Weinstock, Leonard
    Chang, Lin
    Heimanson, Zeev
    Lembo, Anthony
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (09) : 689 - 699
12345